Journal:Acta Cryst F:S2053230X25006181

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 8: Line 8:
<scene name='10/1087727/021_Fig_3a_Cut_Label_2x/1'>021 Fig 3a Cut Label_pse</scene>
<scene name='10/1087727/021_Fig_3a_Cut_Label_2x/1'>021 Fig 3a Cut Label_pse</scene>
<scene name='10/1087727/021_Fig_3b_Cut_Label_4x_pse/1'>021 Fig 3b Cut Label 4x_pse</scene>
<scene name='10/1087727/021_Fig_3b_Cut_Label_4x_pse/1'>021 Fig 3b Cut Label 4x_pse</scene>
 +
 +
<jmol>
 +
<jmolButton>
 +
<text>animation</text>
 +
<script>
 +
var a = [1,5];
 +
for(var i IN a) {
 +
script /wiki/scripts/10/1087727/021_Fig_3a_Cut_Label_2x/1.spt; delay 0.5
 +
script /wiki/scripts/10/1087727/021_Fig_3b_Cut_Label_4x_pse/1.spt; delay 0.5;
 +
}
 +
</script>
 +
</jmolButton>
 +
</jmol>
Bacteria contain either one of two pathways to make menaquinone, the classical or futalosine pathways, and MenD catalyses the first irreversible step in the classical pathway. It takes two substrates, 2-oxoglutarate and isochorismate and converts them to SEPHCHC via a series of reactions involving covalent ThDP-bound intermediates. We have solved several structures of MenD from the listeria-causing pathogen Listeria monocytogenes. Analysis of the structures show a typical <scene name='10/1087727/021_fig_2a_png/5'>ThDP-dependent three-domain</scene> (PP, PYR, TH3 domain) fold similar to other MenD enzymes. Our first structure, captured in the <scene name='10/1087727/021_fig_2a_cut_pse/1'>ThDP cofactor-bound form</scene> has enabled us to visualise and understand how the co-factor binds. By comparing this structure to one without ThDP-bound (apo) in the protein databank we can see how the enzyme active site partially-closes around the co-factor. In our second structure we were able to capture reactivity within the crystal with an in-crystallo formed <scene name='10/1087727/021_Fig_3b_cut_x_pse/1'>covalent ThDP-intermediate (Intermediate I) bound in the active site</scene>. Studying the shape and interactions of this intermediate helps us understand more about the chemistry of the enzyme.
Bacteria contain either one of two pathways to make menaquinone, the classical or futalosine pathways, and MenD catalyses the first irreversible step in the classical pathway. It takes two substrates, 2-oxoglutarate and isochorismate and converts them to SEPHCHC via a series of reactions involving covalent ThDP-bound intermediates. We have solved several structures of MenD from the listeria-causing pathogen Listeria monocytogenes. Analysis of the structures show a typical <scene name='10/1087727/021_fig_2a_png/5'>ThDP-dependent three-domain</scene> (PP, PYR, TH3 domain) fold similar to other MenD enzymes. Our first structure, captured in the <scene name='10/1087727/021_fig_2a_cut_pse/1'>ThDP cofactor-bound form</scene> has enabled us to visualise and understand how the co-factor binds. By comparing this structure to one without ThDP-bound (apo) in the protein databank we can see how the enzyme active site partially-closes around the co-factor. In our second structure we were able to capture reactivity within the crystal with an in-crystallo formed <scene name='10/1087727/021_Fig_3b_cut_x_pse/1'>covalent ThDP-intermediate (Intermediate I) bound in the active site</scene>. Studying the shape and interactions of this intermediate helps us understand more about the chemistry of the enzyme.

Revision as of 11:09, 25 August 2025

LmoMenD monomer (PDB entry 9e9b) with PYR (green), TH3 (orange) and PP (blue) domains.

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Joel L. Sussman, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools